AKT1 and familial dilated cardiomyopathy: Long-term RORα agonist supplementary suppressed mitochondrial fission and promoted mitochondrial biogenesis and mitophagy via sirtuin 6 (SIRT6)/AMPK/PGC-1α/protein kinase B (AKT) axis to delay the progression of DCM [39].